A new treatment breakthrough at University of Utah Health is bringing relief to children with Down syndrome and sleep apnea. Families are finding new hope as kids breathe—and sleep—more easily.
Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The treatment is a once-nightly oral pill designed specifically for obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results